Petros Pharmaceuticals Inc
Drug Manufacturers-Specialty & Generic
Healthcare
PTPI
2.07 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
1.45
52 week high
6.55
high
1.50
52 week low
1.32
low
1.32
growth
-53.44 %
previous Close
1.41
P/E ratio
-1
market cap
6.02 M
div yield
0
usd
Jun 2023
qoq
revenue
1.99 B
79.00 %
net incoming
-2.55 B
-1.00 %
eps
-1.20 %
-81.33 %
eps surprise
0.00 %
net profit margin
-127.72 %
8585.00 %
operating incoming
-2.46 B
-188.00 %
net change in cash
-1.68 B
-151.00 %
cash on hand
7.38 B
88.00 %
cost of revenue
514 M
93.00 %
top top